Gary R. Maharaj - Sep 15, 2021 Form 4 Insider Report for SURMODICS INC (SRDX)

Role
President & CEO, Director
Signature
/s/ John Manders on behalf of Gary R. Maharaj
Stock symbol
SRDX
Transactions as of
Sep 15, 2021
Transactions value $
-$343,359
Form type
4
Date filed
9/17/2021, 04:04 PM
Next filing
Oct 5, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRDX Common Stock Sale -$58.4K -1.03K -0.62% $56.68 164K Sep 15, 2021 Direct F1, F2, F3
transaction SRDX Common Stock Sale -$285K -4.97K -3.03% $57.34 159K Sep 15, 2021 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2021.
F2 Reflects the weighted average price of 1,030 shares of common stock of Surmodics, Inc. sold by the reporting person in multiple transactions on September 15, 2021 with sale prices ranging from $56.13 to $57.12 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3 Includes 98 shares acquired through the Employee Stock Purchase Plan for the phase ending August 31, 2021.
F4 Reflects the weighted average price of 4,970 shares of common stock of Surmodics, Inc. sold by the reporting person in multiple transactions on September 15, 2021 with sale prices ranging from $57.16 to $57.57 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.